SG11201500396TA - Tumor vaccination - Google Patents
Tumor vaccinationInfo
- Publication number
- SG11201500396TA SG11201500396TA SG11201500396TA SG11201500396TA SG11201500396TA SG 11201500396T A SG11201500396T A SG 11201500396TA SG 11201500396T A SG11201500396T A SG 11201500396TA SG 11201500396T A SG11201500396T A SG 11201500396TA SG 11201500396T A SG11201500396T A SG 11201500396TA
- Authority
- SG
- Singapore
- Prior art keywords
- tumor vaccination
- vaccination
- tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12181821.5A EP2703001A1 (en) | 2012-08-26 | 2012-08-26 | Tumor vaccination |
US201261744008P | 2012-09-17 | 2012-09-17 | |
PCT/EP2013/067653 WO2014033097A1 (en) | 2012-08-26 | 2013-08-26 | Tumor vaccination |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201500396TA true SG11201500396TA (en) | 2015-02-27 |
Family
ID=46785268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201500396TA SG11201500396TA (en) | 2012-08-26 | 2013-08-26 | Tumor vaccination |
Country Status (13)
Country | Link |
---|---|
US (1) | US10792483B2 (en) |
EP (2) | EP2703001A1 (en) |
JP (1) | JP2015530379A (en) |
KR (1) | KR101714281B1 (en) |
CN (1) | CN104640553A (en) |
AU (1) | AU2013307344B2 (en) |
CA (1) | CA2879739C (en) |
ES (1) | ES2586234T3 (en) |
HU (1) | HUE030407T2 (en) |
MX (1) | MX357648B (en) |
RU (1) | RU2015110690A (en) |
SG (1) | SG11201500396TA (en) |
WO (1) | WO2014033097A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2703001A1 (en) | 2012-08-26 | 2014-03-05 | XAX Kft. | Tumor vaccination |
US11911629B2 (en) | 2013-03-11 | 2024-02-27 | NeurEM Therapeutics, Inc. | Treatment of primary and metastatic brain cancers by transcranial electromagnetic treatment |
US11759650B2 (en) | 2013-03-11 | 2023-09-19 | NeuroEM Therapeutics, Inc. | Immunoregulation, brain detoxification, and cognitive protection by electromagnetic treatment |
US11813472B2 (en) | 2013-03-11 | 2023-11-14 | NeuroEM Therapeutics, Inc. | Systems for sensing proper emitter array placement |
US11752356B2 (en) | 2013-03-11 | 2023-09-12 | NeuroEM Therapeutics, Inc. | Systems for controlling power to differently loaded antenna arrays |
CN104491464A (en) * | 2014-11-18 | 2015-04-08 | 四川金堂海纳生物医药技术研究所 | Oral administration medicine for treating tongue cracking symptom and preparation method thereof |
WO2018058125A1 (en) * | 2016-09-26 | 2018-03-29 | Ensemble Group Holdings | Methods of assessing and treating cancer in subjects having dysregulated lymphatic systems |
KR101856904B1 (en) * | 2017-07-28 | 2018-05-11 | 동아대학교 산학협력단 | Antibody specifically binding to PAUF and use thereof |
WO2019204507A1 (en) * | 2018-04-18 | 2019-10-24 | Biomadison, Inc. | Methods for determining vaccine potency |
WO2020198145A1 (en) * | 2019-03-22 | 2020-10-01 | The Johns Hopkins University | Gene delivery particles to induce tumor-derived antigen presenting cells |
RU2722268C1 (en) * | 2019-12-06 | 2020-05-28 | Федеральное государственное автономное образовательное учреждение высшего образования «Дальневосточный федеральный университет» (ДВФУ) | Biotherapy method of laboratory rats with grafted glioblastoma |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57130920A (en) * | 1981-02-09 | 1982-08-13 | Zenyaku Kogyo Kk | Antitumor agent and its preparation |
JPS58157706A (en) * | 1982-03-12 | 1983-09-19 | Norin Suisansyo Kajiyu Shikenjo | Fruit thinning agent of fruit tree |
JPS5936619A (en) * | 1982-08-23 | 1984-02-28 | Tsumura Juntendo Inc | Carcinostatic adjuvant |
US4712559A (en) * | 1985-06-28 | 1987-12-15 | Bsd Medical Corporation | Local current capacitive field applicator for interstitial array |
US5099756A (en) * | 1989-06-01 | 1992-03-31 | Harry H. Leveen | Radio frequency thermotherapy |
US7429471B2 (en) * | 2000-02-23 | 2008-09-30 | The Trustees Of The University Of Pennsylvania | Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
US6904323B2 (en) | 2003-05-14 | 2005-06-07 | Duke University | Non-invasive apparatus and method for providing RF energy-induced localized hyperthermia |
JP4238279B2 (en) * | 2006-01-06 | 2009-03-18 | セルメディシン株式会社 | Immune adjuvant |
US8019414B2 (en) * | 2006-04-05 | 2011-09-13 | Novocure Ltd. | Treating cancer using electromagnetic fields in combination with other treatment regimens |
US20090018613A1 (en) * | 2006-08-02 | 2009-01-15 | Genestim, Llc | Regulation of vascular endothelial growth factor (vegf) gene expression in tissue via the application of electric and/or electromagnetic fields |
DE102006050369A1 (en) * | 2006-10-25 | 2008-04-30 | Oncotherm Kft. | Hyperthermia device for the selective treatment and monitoring of surface tissue |
CN102015753A (en) | 2008-01-25 | 2011-04-13 | 海德堡吕布莱希特-卡尔斯大学 | Hydrophobic modified preS-derived peptides of hepatitis b virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver |
EP2082777A1 (en) | 2008-01-27 | 2009-07-29 | Oncotherm Kft. | Flexible and porous large-area electrode for heating |
EP2153866A1 (en) * | 2008-08-14 | 2010-02-17 | Oncotherm Kft. | Portable radiofrequency hyperthermia device with flexible treatment electrode for electric field capacitive coupled energy transfer |
EP2174689A1 (en) * | 2008-10-13 | 2010-04-14 | Oncotherm Kft. | Radiofrequency hyperthermia device with target feedback signal modulation |
EP2177336A1 (en) | 2008-10-17 | 2010-04-21 | Grupo Antolin-Ingenieria, S.A. | Method for manufacturing a vehicle trim panel |
GB2476315A (en) | 2009-12-21 | 2011-06-22 | Rec Wafer Norway As | Cleaning a stack of thin wafers |
EP2515995A1 (en) * | 2009-12-23 | 2012-10-31 | Hitops GmbH | New use of pulsed radio frequency |
EP2703001A1 (en) | 2012-08-26 | 2014-03-05 | XAX Kft. | Tumor vaccination |
-
2012
- 2012-08-26 EP EP12181821.5A patent/EP2703001A1/en not_active Withdrawn
-
2013
- 2013-08-26 MX MX2015002578A patent/MX357648B/en active IP Right Grant
- 2013-08-26 EP EP13756090.0A patent/EP2780024B1/en active Active
- 2013-08-26 CA CA2879739A patent/CA2879739C/en active Active
- 2013-08-26 ES ES13756090.0T patent/ES2586234T3/en active Active
- 2013-08-26 SG SG11201500396TA patent/SG11201500396TA/en unknown
- 2013-08-26 CN CN201380044773.3A patent/CN104640553A/en active Pending
- 2013-08-26 RU RU2015110690A patent/RU2015110690A/en not_active Application Discontinuation
- 2013-08-26 WO PCT/EP2013/067653 patent/WO2014033097A1/en active Application Filing
- 2013-08-26 US US14/424,027 patent/US10792483B2/en active Active
- 2013-08-26 KR KR1020157005982A patent/KR101714281B1/en active IP Right Grant
- 2013-08-26 HU HUE13756090A patent/HUE030407T2/en unknown
- 2013-08-26 JP JP2015528982A patent/JP2015530379A/en active Pending
- 2013-08-26 AU AU2013307344A patent/AU2013307344B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP2780024B1 (en) | 2016-05-25 |
AU2013307344B2 (en) | 2016-08-25 |
HUE030407T2 (en) | 2017-05-29 |
CA2879739C (en) | 2017-01-31 |
ES2586234T3 (en) | 2016-10-13 |
AU2013307344A1 (en) | 2015-02-26 |
JP2015530379A (en) | 2015-10-15 |
KR20150043375A (en) | 2015-04-22 |
MX2015002578A (en) | 2015-06-10 |
US20150217099A1 (en) | 2015-08-06 |
KR101714281B1 (en) | 2017-03-09 |
WO2014033097A1 (en) | 2014-03-06 |
CN104640553A (en) | 2015-05-20 |
EP2780024A1 (en) | 2014-09-24 |
US10792483B2 (en) | 2020-10-06 |
RU2015110690A (en) | 2016-10-20 |
MX357648B (en) | 2018-07-18 |
EP2703001A1 (en) | 2014-03-05 |
CA2879739A1 (en) | 2014-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207967A1 (en) | Vaccine | |
HK1211475A1 (en) | Combination therapy | |
GB201217018D0 (en) | Methods | |
PL2647387T3 (en) | Vaccine Composition | |
SG11201500396TA (en) | Tumor vaccination | |
EP2876161A4 (en) | Vaccine | |
GB201223386D0 (en) | Vaccine | |
ZA201500656B (en) | Marker vaccine | |
GB201217439D0 (en) | Combination therapy | |
HK1207152A1 (en) | Multivalent breast cancer vaccine | |
GB201220129D0 (en) | Methods | |
GB201207305D0 (en) | Therapy | |
GB201208874D0 (en) | Methods | |
HK1210426A1 (en) | Combination therapy | |
ZA201402071B (en) | Vaccine therapy | |
GB201204280D0 (en) | Methods | |
EP2804853A4 (en) | Therapeutic uses | |
GB201208756D0 (en) | Methods | |
DK2846829T3 (en) | Vaccine combinations | |
GB201217321D0 (en) | Vaccine | |
GB201210226D0 (en) | Vaccine | |
GB201206169D0 (en) | Vaccine | |
GB201205599D0 (en) | Vaccine | |
GB201202090D0 (en) | Vaccine | |
GB201107549D0 (en) | Cancer vaccine |